GlassScriptPhysician profile
Daveed D Frazier
NPI 1518048446
$111,008.95
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $26K · 2021: $16K · 2022: $20K · 2023: $17K · 2024: $3,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $554 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $18,737.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $554.40 |
| Food and Beverage | $487.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $107,290.42 | 2019-2023 | Xlif |
| Globus Medical, INC. | $2,528.77 | 2024 | Xlif |
| Spineology INC. | $565.69 | 2019-2024 | Optimesh Expandable Interbody Fusion System |
| Curiteva, INC. | $284.84 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $116.29 | 2023 | Exparel, Iovera |
| Highridge Medical LLC | $86.45 | 2024 | Vital |
| Nevro Corp. | $36.79 | 2021 | |
| Si-Bone, INC. | $34.69 | 2020-2021 | |
| Spinal Simplicity, LLC | $30.58 | 2021 | |
| Orthofix Medical, INC. | $19.04 | 2019-2020 | |
| Royal Biologics, INC. | $15.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$636,487.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daveed Frazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.